Your browser doesn't support javascript.
loading
TGIF1 functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
Parajuli, Parash; Singh, Purba; Wang, Zhe; Li, Lianna; Eragamreddi, Sailaja; Ozkan, Seval; Ferrigno, Olivier; Prunier, Celine; Razzaque, Mohammed S; Xu, Keli; Atfi, Azeddine.
Afiliación
  • Parajuli P; Cellular and Molecular Pathogenesis Division, Department of Pathology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
  • Singh P; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Wang Z; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Li L; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Eragamreddi S; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Ozkan S; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Ferrigno O; Centre de Recherche Saint-Antoine, CRSA, Inserm, Sorbonne Universités, Paris, France.
  • Prunier C; Centre de Recherche Saint-Antoine, CRSA, Inserm, Sorbonne Universités, Paris, France.
  • Razzaque MS; Department of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
  • Xu K; Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Atfi A; Cellular and Molecular Pathogenesis Division, Department of Pathology and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
EMBO J ; 38(13): e101067, 2019 07 01.
Article en En | MEDLINE | ID: mdl-31268604
A prominent function of TGIF1 is suppression of transforming growth factor beta (TGF-ß) signaling, whose inactivation is deemed instrumental to the progression of pancreatic ductal adenocarcinoma (PDAC), as exemplified by the frequent loss of the tumor suppressor gene SMAD4 in this malignancy. Surprisingly, we found that genetic inactivation of Tgif1 in the context of oncogenic Kras, KrasG12D , culminated in the development of highly aggressive and metastatic PDAC despite de-repressing TGF-ß signaling. Mechanistic experiments show that TGIF1 associates with Twist1 and inhibits Twist1 expression and activity, and this function is suppressed in the vast majority of human PDACs by KrasG12D /MAPK-mediated TGIF1 phosphorylation. Ablating Twist1 in KrasG12D ;Tgif1KO mice completely blunted PDAC formation, providing the proof-of-principle that TGIF1 restrains KrasG12D -driven PDAC through its ability to antagonize Twist1. Collectively, these findings pinpoint TGIF1 as a potential tumor suppressor in PDAC and further suggest that sustained activation of TGF-ß signaling might act to accelerate PDAC progression rather than to suppress its initiation.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Represoras / Proteínas Nucleares / Proteínas Proto-Oncogénicas p21(ras) / Proteínas de Homeodominio / Carcinoma Ductal Pancreático / Proteína 1 Relacionada con Twist Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO J Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas Represoras / Proteínas Nucleares / Proteínas Proto-Oncogénicas p21(ras) / Proteínas de Homeodominio / Carcinoma Ductal Pancreático / Proteína 1 Relacionada con Twist Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: EMBO J Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos